stockrow
Friday 6 November 2026
Export ACHC’s income statement to Excel — free account
Acadia Healthcare Company, Inc.
ACHC Healthcare Medical Care Facilities
Acadia Healthcare Company, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 5.04% from fiscal 2024.
- Revenue
- +5.14%
- EPS
- +6.30%
- Free cash flow
- +196.5%
- Total debt
- +1.87%
Quarter to September 2026, against a year earlier
37.14
2.35
+6.75%
Follow ACHC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.39 | 0.63 | 0.80 | 0.73 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 232.81 | |
P/Operating CF |
(14.92) | 34.41 | 16.55 | 25.53 | |
P/B ratio |
0.66 | 1.08 | 1.36 | 1.24 | |
Price to Tangible BV |
2.32 | 3.79 | 4.66 | 4.12 | |
EV/Sales |
1.10 | 1.33 | 1.46 | 1.37 | |
EV/EBITDA |
6.28 | 7.56 | 9.12 | 8.68 | |
EV/Operating CF |
27.70 | 24.65 | 23.40 | 19.94 | |
EV/FCF |
(8.78) | (17.83) | (49.10) | 436.71 | |
Quick Ratio |
1.09 | 1.29 | 1.19 | 1.20 | |
Current Ratio |
1.55 | 1.71 | 1.57 | 1.60 | |
Net Debt/EBITDA |
24.98 | 17.22 | 16.09 | 12.99 | |
Debt/Assets |
45.23% | 45.56% | 43.53% | 42.35% | |
Debt/Equity |
1.28 | 1.29 | 1.22 | 1.16 | |
Asset Turnover |
0.58 | 0.58 | 0.57 | 0.57 | |
Operating CF/Net income |
0.07 | 14.99 | 14.83 | 2.84 | |
Capex/Depreciation |
(1.96) | (1.12) | (0.55) | (0.80) | |
Interest Coverage |
1.26 | 2.19 | 2.30 | 3.06 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
65.73% | 66.33% | 64.68% | 64.83% | |
Intangible Assets out of Total Assets |
0.25 | 0.25 | 0.25 | 0.25 | |
Share Based Compensation of Revenue |
0.79% | 0.96% | 1.27% | 1.03% | |
Graham Net Nets |
(2.15) | (1.30) | (1.01) | (1.06) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(85.98%) | (52.33%) | (42.16%) | (45.18%) | |
Free Cash Flow Yield |
(32.33%) | (11.88%) | (3.74%) | 0.43% | |
Revenue per Share |
9.06 | 9.16 | 9.53 | 9.85 | |
Operating CF per Share |
(0.95) | 0.68 | 1.78 | 1.08 | |
Capex per Share |
(1.02) | (0.66) | (0.31) | (0.48) | |
Free Cash Flow per Share |
(1.97) | 0.01 | 1.47 | 0.60 | |
Cash per Share |
1.47 | 1.75 | 1.89 | 1.80 | |
Shareholders Equity per Share |
21.49 | 21.63 | 21.79 | 22.25 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
21.49 | 21.63 | 21.79 | 22.25 | |
Free Cash Flow |
(178.79) | 1.35 | 133.63 | 54.54 | |
Working Capital |
288.95 | 347.84 | 307.71 | 329.29 | |
Capital Expenditures |
(92.49) | (60.18) | (28.44) | (43.34) | |
Net Current Asset Value |
(2,764.35) | (2,750.98) | (2,721.92) | (2,650.78) | |
EV/EBIT |
9.42 | 11.41 | 14.54 | 14.07 | |
Capex to Sales |
0.11 | 0.07 | 0.03 | 0.05 | |
Price to Operating Income |
3.32 | 5.38 | 7.92 | 7.50 | |
| Other line items | |||||
Average Receivables |
402.97 | 434.19 | 439.65 | 466.11 | |
Average Payables |
191.55 | 173.11 | 177.54 | 159.25 | |
Average Assets |
5,742.18 | 5,847.02 | 5,927.34 | 5,983.67 | |
Average Common Equity |
2,511.34 | 2,499.92 | 2,528.55 | 2,571.39 |
Columns are period end dates · fundamentals updated 6 Nov 2026